These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 25853443

  • 1. Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.
    Chia SN, Smith HB, Hammer HM, Kemp EG.
    Eye (Lond); 2015 Jun; 29(6):748-56. PubMed ID: 25853443
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D, Dürr C, Paulsen F, Kaulich T, Bartz-Schmidt KU.
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [Abstract] [Full Text] [Related]

  • 9. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
    McCannel TA, Kamrava M, Demanes J, Lamb J, Bartlett JD, Almanzor R, Chun M, McCannel CA.
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
    [Abstract] [Full Text] [Related]

  • 10. Safety of pars plana vitrectomy in eyes with plaque-irradiated posterior uveal melanoma.
    Bansal AS, Bianciotto CG, Maguire JI, Regillo CD, Shields JA, Shields CL.
    Arch Ophthalmol; 2012 Oct; 130(10):1285-90. PubMed ID: 23044941
    [Abstract] [Full Text] [Related]

  • 11. [Therapy of radiation resistant malignant uveal melanoma with endoresection by pars plana vitrectomy in two patients].
    Schmidt JC, Brieden-Azvedo S, Nietgen GW.
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):800-4. PubMed ID: 11805872
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endoresection utilizing pars plana vitrectomy for benign and malignant intraocular tumors.
    Reichstein D, Karan K.
    Curr Opin Ophthalmol; 2019 May; 30(3):151-158. PubMed ID: 30883440
    [Abstract] [Full Text] [Related]

  • 15. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L, Wackernagel W, Avian A, Mayer C, Schneider M, Winkler P, Langmann G.
    Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comment on: 'Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma'.
    Chia SN, Smith HB, Kemp EG.
    Br J Ophthalmol; 2014 Apr; 98(4):571. PubMed ID: 24390168
    [No Abstract] [Full Text] [Related]

  • 18. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ, Salvi S, Rundle PA, Errington DG, Kacperek A, Rennie IG.
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool.
    Wright PK, Damato BE.
    J R Coll Surg Edinb; 1999 Aug; 44(4):260-4. PubMed ID: 10453150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.